‘Prostate Screening Saved My Life’—Is That Really True in Most Cases? - Summary - MDSpire
Commentary & Perspectives

‘Prostate Screening Saved My Life’—Is That Really True in Most Cases?

Prostate specific antigen (PSA) screening remains one of the most controversial of “standard” medical practices. As recently as the 2026 Super Bowl, one of the more unusual TV advertisements, sponsore...

Share

Derek Raghavan, MD, PhD, discusses the contentious issue of prostate-specific antigen (PSA) screening for prostate cancer, highlighted by a recent TV advertisement celebrating its benefits. Despite claims of life-saving outcomes, experts criticize the lack of overall survival benefits demonstrated in the European Prostate Cancer Study, questioning the utility of PSA in early-stage detection and its potential to cause harm. The commentary advocates for a balanced health policy regarding PSA screening amidst ongoing confusion in medical practice.

Original Source(s)

‘Prostate Screening Saved My Life’—Is That Really True in Most Cases?

  • by Derek Raghavan

  • April 20, 2026

Related Content

This Week’s Biopharma News: KRAS Breakthrough and ADC Momentum

Revolution’s KRAS breakthrough, strong ADC signals from GSK, and shifting regulatory and dealmaking dynamics define this week in biopharma

  • April 21, 2026

  • 4 min
Modeling the Genetics of Uveal Melanoma

Researchers have developed a genetically engineered mouse model that mirrors the genetic evolution of uveal melanoma

  • April 21, 2026

  • 3 min
This Week’s CGT News: New FDA Genome Editing Guidance 

Our latest roundup highlights tighter FDA expectations for genome editing safety, advances in CRISPR precision and delivery, and continued momentum for off-the-shelf CAR-T

  • April 20, 2026

  • 6 min